» Articles » PMID: 33593717

Role of Plasma Soluble Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 and MicroRNA-98 in Severity and Risk of Coronary Artery Disease

Overview
Journal Balkan Med J
Specialty General Medicine
Date 2021 Feb 17
PMID 33593717
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Coronary artery diseases are the most important cause of premature death, and these diseases are predominantly related to atherosclerosis. Soluble lectin-like oxidized low-density lipoprotein receptor-1 and microRNAs are closely associated with atherosclerotic coronary heart diseases.

Aims: To investigate the relationship between the severity and risk of coronary artery disease and plasma soluble lectin-like oxidized low-density lipoprotein receptor-1 and miR-98.

Study Design: Case-control study.

Methods: Angiographically documented patients with 38 single-vessel, 75 double-vessel, and 62 multi-vessel coronary artery disease; 62 healthy control participants; and 24-hour hypoxic (1% oxygen) human umbilical vein endothelial cells were included in this study. Circulating soluble lectin-like oxidized low-density lipoprotein receptor-1 concentrations were determined through enzyme-linked immunosorbent assays, and miR-98 expressions were measured by quantitative real-time polymerase chain reaction.

Results: The expressions of plasma soluble lectin-like oxidized low-density lipoprotein receptor-1 levels were progressively and significantly higher in patients with single-vessel, double-vessel, and multi-vessel coronary artery disease than in healthy controls (p<0.001). Circulating soluble lectin-like oxidized low-density lipoprotein receptor-1 concentrations in female patients with multi-vessel, double-vessel, and single-vessel coronary artery disease had evidently elevated compared with that in male patients (p<0.001). Plasma soluble lectin-like oxidized low-density lipoprotein receptor-1 levels were remarkably increased in females with coronary artery disease in different age groups compared with the males in the same age groups (p<0.001). Patients with single-vessel (areas under the curve=0.879), double-vessel (area under the curve=0.928), and multi-vessel (area under the curve=0.943) coronary artery disease have been clearly differentiated from healthy participants with respect to high sensitivity and specificity. The expression of miR-98 was noticeably downregulated in patients with single-, double- and multi-vessel occluded coronary artery disease and in hypoxic human umbilical vein endothelial cell compared with controls (p<0.001). Significantly elevated lectin-like oxidized low-density lipoprotein receptor-1 and caspase-3 activity and remarkably decreased cellular viability in hypoxic injured human umbilical vein endothelial cell. On the contrary, mimic of miR-98 markedly reduced caspase-3 and lectin-like oxidized low-density lipoprotein receptor-1 levels and highly increased cellular viability.

Conclusion: Elevated circulating plasma soluble lectin-like oxidized low-density lipoprotein receptor-1 levels have a potential impact to identify the severity of coronary artery disease and have a strong correlation with aging as well as the female gender. Reduced plasma miR-98 level is possibly considered a risk factor for coronary artery disease, and agomiR-98 prevents atherosclerosis and cellular injury by targeting lectin-like oxidized low-density lipoprotein receptor-1.

Citing Articles

mir-98-5p regulates gluconeogenesis and lipogenesis by targeting PPP1R15B in hepatocytes.

Khan R, Verma A, Datta M J Cell Commun Signal. 2023; 17(3):881-895.

PMID: 36917438 PMC: 10409962. DOI: 10.1007/s12079-023-00735-0.


Overexpression of miR-126 Protects Hypoxic-Reoxygenation-Exposed HUVEC Cellular Injury through Regulating LRP6 Expression.

Sheikh M, Almaeen A, Alduraywish A, Alomair B, Salma U, Fei L Oxid Med Cell Longev. 2022; 2022:3647744.

PMID: 35082967 PMC: 8786472. DOI: 10.1155/2022/3647744.


Association of circulating soluble lectin-like oxidized low-density lipoprotein receptor-1 with inflammatory markers and urinary albumin excretion in patients with type 2 diabetes.

Takebayashi K, Suzuki T, Yamauchi M, Hara K, Tsuchiya T, Inukai T SAGE Open Med. 2022; 9:20503121211064468.

PMID: 34992779 PMC: 8724995. DOI: 10.1177/20503121211064468.


Effect of Dietary Fatty Acids on MicroRNA Expression Related to Metabolic Disorders and Inflammation in Human and Animal Trials.

MacDonald-Ramos K, Martinez-Ibarra A, Monroy A, Miranda-Rios J, Cerbon M Nutrients. 2021; 13(6).

PMID: 34072137 PMC: 8226960. DOI: 10.3390/nu13061830.


Therapeutic Value of miRNAs in Coronary Artery Disease.

Sheikh M, Alduraywish A, Almaeen A, Alruwali M, AlRuwaili R, Alomair B Oxid Med Cell Longev. 2021; 2021:8853748.

PMID: 33953838 PMC: 8057887. DOI: 10.1155/2021/8853748.


References
1.
Inoue N, Okamura T, Kokubo Y, Fujita Y, Sato Y, Nakanishi M . LOX index, a novel predictive biochemical marker for coronary heart disease and stroke. Clin Chem. 2010; 56(4):550-8. DOI: 10.1373/clinchem.2009.140707. View

2.
Hofmann A, Brunssen C, Wolk S, Reeps C, Morawietz H . Soluble LOX-1: A Novel Biomarker in Patients With Coronary Artery Disease, Stroke, and Acute Aortic Dissection?. J Am Heart Assoc. 2020; 9(1):e013803. PMC: 6988168. DOI: 10.1161/JAHA.119.013803. View

3.
Zhao Z, Xu Y, Li S, Guo J, Sun J, Hong J . Baseline Serum sLOX-1 Concentrations Are Associated with 2-Year Major Adverse Cardiovascular and Cerebrovascular Events in Patients after Percutaneous Coronary Intervention. Dis Markers. 2019; 2019:4925767. PMC: 6854229. DOI: 10.1155/2019/4925767. View

4.
Paquette M, Dufour R, Baass A . Scavenger Receptor LOX1 Genotype Predicts Coronary Artery Disease in Patients With Familial Hypercholesterolemia. Can J Cardiol. 2017; 33(10):1312-1318. DOI: 10.1016/j.cjca.2017.07.480. View

5.
Sheikh M . Diagnostic Role of Plasma MicroRNA-21 in Stable and Unstable Angina Patients and Association with Aging. Cardiol Res Pract. 2020; 2020:9093151. PMC: 7174930. DOI: 10.1155/2020/9093151. View